An unusual case of immunoblastic lymphadenopathy (IBL) with circulating CD3"CD4+cells is reported. A lymph node biopsy specimen showed the characteristic features of IBL. Two-color analyses demonstrated that the circulating abnormal cells were CD3~, CD4+, HLA-DR+, and CD25". Chromosomal analysis revealed unrelated clones in the lymph node. Though 48% of the peripheral blood lymphocytes were abnormal, no clonal rearrangement of the TcR fi chain gene was detected in the peripheral blood. This case might point out the possibility that some cases of IBL truly had no TcR gene rearrangement and were dysplasias. (Internal Medicine 32: 455-458, 1993) 
Introduction
Immunoblastic rymphadenopathy (IBL) is a systemic lymphoproliferative disease characterized by generalized lymphadenopathy, hepatosplenomegaly, skin rash, and immunological abnormalities ( 1^). As a result of many studies, it has become clear that manycases of IBL are identified as T-cell lymphoma (IBL-like T-cell lymphoma) (5-9). However, there remains a problem that there is no clonal rearrangement of the TcR B gene in 30% of IBL (10). It has been thought that this problem is due to the inability to find clonal rearrangements for a slight underlying monoclonal proliferation below the threshold of detection.
In this paper we describe many circulating abnormal T cells detected in a patient with IBL by two color analyses. But neither cytogenetic nor immunogenotypicanalysis revealed clonality despite the presence of many immunophenotypically abnormal T cells. Our data show dysplastic features of IBL.
Case Report
A 54-year-old Japanese womanwas admitted to our hospital in June 1991 because of skin rash. She had had recurrent episodes of systemic lymphadenopathy, fever and skin rash after taking some analgesic agents (ibuprofen, etc.) during the preceding two years. The skin rash had disappeared spontaneously on the first occasion, and after taking prednisolone on the second occasion. On physical examination, generalized lymphadenopathy, fever, skin rash and hepatosplenomegaly were found. A biopsied right cervical lymph node exhibited the typical features of IBL. The cervical lymph node biopsy specimenshoweddiffuse effacement of the nodal architecture with complete absence of germinal center and prominently arborizing postcapillary venules (Fig. la) . Proliferating cells consisted of small lymphocytes, plasma cells, large immunoblasts with pale cytoplasma, and eosinophils (Fig. lb) . The pale cells were stained with UCHL-1. The chromosomal analysis of the lymph node revealed a clone with 3 trisomy (4/24 mitotic cells) and another clone with 21 trisomy (9/24 mitotic cells) ( Table 1) . These findings were believed to indicate the presence of karyotypically unrelated abnormal clones. Laboratory findings (Table 1) showed the WBCto be 4,900/jil, and decreased gamma-globulin level in the serum was found. The number of CD4+plus CD8+cells exceeded that of CD3+cells. Serum antibody against human T-cell leukemia virus (HTLV)-I and HTLV-I proviral DNAof the peripheral blood mononuclear cells (PBMNC) were negative. She was diagnosed as IBL. The patient received prednisolone therapy. Soon after beginning the therapy, the lymph node swelling, hepatosplenomegaly and skin rash subsided. She was discharged on August 1991, but was soon readmitted because of pneumonia. She died of pneumonia in November 1991.
Materials and Methods

Lymphocyte subset identification
For two-color immunofluorescence analyses, PBMNC were incubated for 30 min on ice with monoclonal antibody (MoAb) conjugated to fluorescence isothiocyanate (FITC) and biotin. 
Sorting of CD3~CD4+ lymphocytes
PBMNCwere incubated with conjugated anti-Leu 4 (CD3) and Leu 3a (CD4) and sorted in CD3"CD4+fractions on a 
Results
Phenotypic findings of circulating abnormal cells before and after treatment The number of CD4+plus CD8+lymphocytes exceeded that of CD3+ lymphocytes in the peripheral blood (PB) and lymph node (LN) ( Table 1) . Two-color analyses showed circulating abnormal cells expressed as CD4+and HLA-DR+but not CD3 or CD25 (Fig. 2) . After prednisolone therapy, the circulating abnormal cells decreased remarkably.
Morphologicalfindings of sorted circulating abnormal cells
Circulating abnormal cells showed a slightly convoluted nucleus with a pale cytoplasm. negative TcR and Ig rearrangement ( Table 1) .
Discussion
The clinical characteristics of this patient were compatible with those of typical IBL except for the reduced serum yglobulin, in contrast to the hypergammaglobulinemia seen in the most cases, and a definite diagnosis was madeon the basis of the histologically characteristic features of the lymph node. The present case was shownto be clonal by immunophenotypic analysis, but not by cytogenetic or immunogenotypic analysis. Malignant T-lineage populations often manifest pan-T antigen loss (12). This phenomenon has not been observed in any nonneoplastic disorder (13). The results suggest that the loss of one or more pan-T markers is a useful phenotypic finding supporting the diagnosis of T-cell lymphoma. In a series of 88 T-cell lymphomas (13), the CD3 was lost in 17/88 (19%). No loss of pan-T antigens is reported in IBL or IBL-like T-cell lymphoma (14). We showed that half of the circulating lymphocytes in this patient were abnormal cells with CD3C D4+surface markers. Sorted circulating abnormal cells showed slightly convoluted nuclei with pale cytoplasm. Although the circulating abnormal cells constituted half of the peripheral mononuclear cells, they did not show TcR rearrangement. As a result of the finding of gene rearrangement in IBL cases, it became clear that manycases ofIBL were identified as IBL-like T-cell lymphoma. However, the problem is that several different frequencies of monoclonal TcR B gene rearrangement are reported to occur in IBL (10), and there is no evidence ofT cell clonality in 30% of the IBL. There are two explanations for this anomaly. First, there was no evidence of T cell clonality because the underlying monoclonal T cell proliferation was below the level of detection in IBL. Previous studies have shownthat gene rearrangement analysis cannot accurately detect a monoclonal population of B or T cells when they account for less than 5% of the cells present in a tissue sample (15). However,in the present case there was no evidence of T cell clonality despite the high percentage (48%) of abnormal PB lymphocytes. Secondly, there is no clonal T cell proliferation of IBL cases in nature. This is precisely whywe understand IBL to be a dysplasia. Nanba and Sasaki ( 1 6) proposed that IBL is a lymphodysplastic syndrome, based on the low rate of TcRgene rearrangement (1/ll). Frizzera et al. (10) emphasized that in about 30%ofIBL cases, as determined by histopathology, no evidence of clonality is found by immunogenotypic analysis. These authors proposed that the designation 'TBL" should be limited to such cases, whereas the term "IBL-like lymphoma"should be reserved for cases shownto be clonal by immunogenotypicanalysis. In the present case we could not detect TcRgene rearrangement despite the numerous abnormal T cells, so this would be a nonneoplastic disease. Immunophenotypic criteria for the diagnosis ofnon-Hodgkin ' s lymphoma. 
